Ergomed - Healthy fundamentals for 2022
Ergomed’s FY21 results showed that adjusted EBITDA of £25.4m was ahead of our estimate of £24.0m and consensus of £23.4m. A strong order book...
3 Views
Ergomed - Healthy CRO segment rebound confirmed
Ergomed released its 2021 trading update. Total 2021 revenues are expected to be approximately £118.6m, up 37.3% y-o-y (our and the consensus...
1.2k Views
Ergomed - US is now the biggest market in the mix
Ergomed has released its full H121 results. H121 revenue numbers were included in the trading update in July 2021, while the full accounts released...
979 Views
Ergomed - Momentum continues with EBITDA upgrades
Ergomed’s H121 trading update highlights that operational momentum continues to be strong following its stellar performance in FY20. The order book...
476 Views
Ergomed - FY21e EBITDA ‘materially ahead’ of consensus
Yesterday, Ergomed held its annual general meeting (AGM) and provided a high-level year to date trading update (four months to end-April 2021). The...
824 Views